 "Top trading ideas by CapitalVia Global Research: Buy TCS, Pidilite")
Grueling optimism of Market towards newer highs driven by RIL and Pharma stocks – Time to stay cautious
The Nifty traded near the important resistance level of 12,000 on Wednesday and if it is able to sustain above this level in the coming trading sessions, it will set the path towards a newer high surpassing the previous high of 12,103. Reliance Industries (RIL),and pharma stocks traded with positive sentiments throughout the day and gained most among indices. Nifty bank closed flat at 31,341 as compared to its opening of 31,340. If we look at crude oil prices, it has come down sharply over the last two trading sessions because of surge in US inventory.
From option chain we can observe that maximum put open interest was seen at 11,900 followed by 11,800 strike, while maximum Call open interest was seen at 12,000 followed by 12,200 strike. For this week, we can expect a range-bound movement of market and some profit booking in PSU bank stocks and pharma stocks.
In the current market scenario, we see some upside movement in the following stocks:
Buy TCS: (Above Rs. 2,140)
Target: Rs 2,190
Stop loss: Rs 2,090
The stock is showing signals of reversal from lower zones, with the support of 200 EMA. Breaking the immediate resistance of 2,140 will bring an upside momentum in the stock. Considering the technical evidence discussed above, we recommend buying the stock above RS 2,140 for the target of Rs 2,190, keeping a stop loss at Rs 2,090 on a closing basis.
Buy Pidilite Industries Limited: (Above Rs 1,334)
Target: Rs 1,420
Stop loss: Rs 1,280
The stock is showing signals of reversal from lower zones, with the support of 200 EMA. Breaking the immediate resistance of 1,334 will bring an upside momentum in the stock. Considering the technical evidence discussed above, we recommend buying the stock above Rs 1,334 for the target of Rs 1420, keeping a stop loss at Rs 1,280 on a closing basis.
Disclaimer: The analyst does not hold position in any of the stocks mentioned above.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%